209 related articles for article (PubMed ID: 26802282)
41. Variability of TSNA in U.S. Tobacco and Moist Smokeless Tobacco Products.
Oldham MJ; Lion KE; Phillips DJ; Morton MJ; Lusso MF; Harris EA; Jordan JL; Franke JE; Strickland JA
Toxicol Rep; 2020; 7():752-758. PubMed ID: 32612935
[TBL] [Abstract][Full Text] [Related]
42. Oral Cancer Risk Assessment for Different Types of Smokeless Tobacco Products Sold Worldwide: A Review of Reviews and Meta-analyses.
Gupta AK; Kanaan M; Siddiqi K; Sinha DN; Mehrotra R
Cancer Prev Res (Phila); 2022 Nov; 15(11):733-746. PubMed ID: 36095092
[TBL] [Abstract][Full Text] [Related]
43. A novel model mouth system for evaluation of In Vitro release of nicotine from moist snuff.
Li P; Zhang J; Sun SH; Xie JP; Zong YL
Chem Cent J; 2013 Nov; 7(1):176. PubMed ID: 24215662
[TBL] [Abstract][Full Text] [Related]
44. Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry.
Stepanov I; Villalta PW; Knezevich A; Jensen J; Hatsukami D; Hecht SS
Chem Res Toxicol; 2010 Jan; 23(1):66-73. PubMed ID: 19860436
[TBL] [Abstract][Full Text] [Related]
45. Evidence supporting product standards for carcinogens in smokeless tobacco products.
Hatsukami DK; Stepanov I; Severson H; Jensen JA; Lindgren BR; Horn K; Khariwala SS; Martin J; Carmella SG; Murphy SE; Hecht SS
Cancer Prev Res (Phila); 2015 Jan; 8(1):20-6. PubMed ID: 25524878
[TBL] [Abstract][Full Text] [Related]
46. Levels of toxins in oral tobacco products in the UK.
McNeill A; Bedi R; Islam S; Alkhatib MN; West R
Tob Control; 2006 Feb; 15(1):64-7. PubMed ID: 16436408
[TBL] [Abstract][Full Text] [Related]
47. Constituent Variations in Smokeless Tobacco Purchased in Mumbai, India.
Stepanov I; Gupta PC; Parascandola M; Yershova K; Jain V; Dhumal G; Hatsukami DK
Tob Regul Sci; 2017 Jul; 3(3):305-314. PubMed ID: 34734108
[TBL] [Abstract][Full Text] [Related]
48. Tobacco alkaloids and tobacco-specific nitrosamines in dust from homes of smokeless tobacco users, active smokers, and nontobacco users.
Whitehead TP; Havel C; Metayer C; Benowitz NL; Jacob P
Chem Res Toxicol; 2015 May; 28(5):1007-14. PubMed ID: 25794360
[TBL] [Abstract][Full Text] [Related]
49. Tobacco specific N-nitrosamines: occurrence and bioassays.
Hoffmann D; Adams JD; Brunnemann KD; Rivenson A; Hecht SS
IARC Sci Publ; 1982; (41):309-18. PubMed ID: 6890526
[TBL] [Abstract][Full Text] [Related]
50. Bacteriome of Moist Smokeless Tobacco Products Consumed in India With Emphasis on the Predictive Functional Potential.
Sajid M; Srivastava S; Kumar A; Kumar A; Singh H; Bharadwaj M
Front Microbiol; 2021; 12():784841. PubMed ID: 35003015
[TBL] [Abstract][Full Text] [Related]
51. Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco.
Djordjevic MV; Brunnemann KD; Hoffmann D
Carcinogenesis; 1989 Sep; 10(9):1725-31. PubMed ID: 2766465
[TBL] [Abstract][Full Text] [Related]
52. Heterogeneity of Harmful Constituent Profiles in Smokeless Tobacco Products from Five African Countries.
Gomez F; Ayo-Yusuf O; Yershova K; Jain V; Alcheva A; Hatsukami DK; Parascandola M; Stepanov I
Chem Res Toxicol; 2023 Dec; 36(12):1901-1911. PubMed ID: 38051542
[TBL] [Abstract][Full Text] [Related]
53. Risk for oral cancer from smokeless tobacco.
Janbaz KH; Qadir MI; Basser HT; Bokhari TH; Ahmad B
Contemp Oncol (Pozn); 2014; 18(3):160-4. PubMed ID: 25520574
[TBL] [Abstract][Full Text] [Related]
54. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches.
Mallock N; Schulz T; Malke S; Dreiack N; Laux P; Luch A
Tob Control; 2024 Feb; 33(2):193-199. PubMed ID: 38378209
[TBL] [Abstract][Full Text] [Related]
55. Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users.
Benowitz NL; Renner CC; Lanier AP; Tyndale RF; Hatsukami DK; Lindgren B; Stepanov I; Watson CH; Sosnoff CS; Jacob P
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):934-42. PubMed ID: 22490317
[TBL] [Abstract][Full Text] [Related]
56. A Survey of N'-Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015.
Ammann JR; Lovejoy KS; Walters MJ; Holman MR
J Agric Food Chem; 2016 Jun; 64(21):4400-6. PubMed ID: 27192054
[TBL] [Abstract][Full Text] [Related]
57. Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products--Florida, January-February 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 May; 48(19):398-401. PubMed ID: 10366135
[TBL] [Abstract][Full Text] [Related]
58. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.
Richter P; Spierto FW
Nicotine Tob Res; 2003 Dec; 5(6):885-9. PubMed ID: 14668072
[TBL] [Abstract][Full Text] [Related]
59. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
[TBL] [Abstract][Full Text] [Related]
60. Tobacco-specific N-nitrosamines in the saliva of habitual male snuff dippers.
Osterdahl BG; Slorach S
Food Addit Contam; 1988; 5(4):581-6. PubMed ID: 3192010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
